Radiologists have a lot to be excited about in 2018 and beyond. Jim Y. Chen, MD, of the department of radiology at Brigham and Women’s Hospital in Boston, explored some recent statistics in a new commentary published by the Journal of the American College of Radiology, detailing what they mean for the specialty this year and in years ahead.

The FDA has issued a voluntary recall of valsartan, due to concerns of an impurity N-nitrosodimethylamine (NDMA), a known carcinogen, which was found in a batch of the drug manufactured in China. Valsartan is commonly used to control hypertension and heart failure.

The National Electrical Manufacturers Association (NEMA) published its updated guidelines for measuring and reporting performance specifications of PET scanners on Friday, July 13.

With seven of the country’s 20 most prominent radiology practices having completed business deals within the last 18 months, the field is witnessing more efforts to consolidate and conserve resources than perhaps ever before.

Federal investigators say former HHS Secretary Tom Price wasted $341,000 of taxpayer money for his use of chartered jets and military aircraft, The New York Times reported Friday.

Association groups see some of CMS's new proposals as a missed opportunity to encourage the move to value-based care.

The escalating trade war between the U.S. government and China could lead to an additional $400 million in medical equipment costs each year, according to a new analysis from the American Action Forum (AAF).

Follow-up imaging for women with non-metastatic breast cancer differs widely across the U.S., research out of the University of California, San Francisco, has found. The key factor in discerning patients' follow-up treatment seems to be where they live.